MAPS is also the abbreviation for The Multidisciplinary Association for Psychedelic Studies.
These folx are working to change thr course of the
war on drugs and make psychedelics and marijuana legetimate medical resources.
They are a membership-based non-profit research and educational organization. They assist scientists to design, obtain approval for, fund, conduct and report on research into the healing and spiritual potentials of
psychedelics and
marijuana.
Their journal MAPS is one of the best published magazines on the subject of psychedelics and their legitamet uses.
Since 1995, MAPS has disbursed over a million dollars to worthy research and educational projects:
Opened an
FDA Drug Master File for
MDMA. This is required before any drug can be researched in
FDA-approved human studies.
Assisted
Dr. Charles Grob to design, obtain approval for and fund the first FDA-approved study in the U.S. to administer MDMA to humans.
Assisted in the design and is funding the world's first government-approved scientific study of the therapeutic use of MDMA (
Spain).
Sponsored the first studies to analyze the purity and potency of street samples of "
Ecstasy" and
medical marijuana.
Funded the successful efforts of
Dr. Donald Abrams to obtain approval for the first human study in 15 years into the
therapeutic use of marijuana, along with a $1 million grant from the
National Institute on Drug Abuse.
Obtained
Orphan Drug designation from the FDA for smoked marijuana in the treatment of
AIDS Wasting Syndrome.
Funded the synthesis of
psilocybin for the first FDA-approved study in twenty-five years to evaluate psilocybin in a patient population.
Supported long-term follow-up studies of pioneering research with
LSD and psilocybin originally conducted in the
1950s and
1960s.
for more info see: www.maps.org